Overall rank by patents
#4,114
Across all tracked assignees
USPTO PatentsView assignee record - 87 granted patents across 19 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY).
The verdict
Daramic holds 87 US patents across 19 technology areas, rank #4,114 of 50,000 tracked assignees.
Daramic, Llc has been granted 87 US utility patents between 2015 and 2025, placing Daramic, Llc at rank #4,114 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 15.4 claims per patent with primary concentration in H01M (PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY). As a US Corporation, Daramic, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Daramic sits between Chanel Parfums Beaute (87 patents, rank #4,110) and Glaxosmithkline Intellectual Property (no. 4) Limited (87 patents, rank #4,118) - the closest US assignees by grant volume. The composite Innovation Score of 48.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 64 grants, compared with 23 in the 2015–2019 window, a +178% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Daramic, Llc's 15.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Daramic, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
CHANEL PARFUMS BEAUTE
87 patents
COMPAGNIE PLASTIC OMNIUM SE
87 patents
Cognitive Systems Corp.
87 patents
D2L Corporation
87 patents
DUMMEN GROUP B.V.
87 patents
F-Secure Corporation
87 patents
FUJIKOKI CORPORATION
87 patents
GlaxoSmithKline Intellectual Property (No. 4) Limited
87 patents
DARAMIC, LLC
87 patents
What this shows Daramic holds 87 patents at rank #4,114, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #4,114 in granted patent volume.
Other assignees with the most granted patents in Daramic's primary technology class.
Daramic's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
49 Top 16% higher than 84% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 1 | 1.1% |
| 2016 | 2 | 2.3% |
| 2017 | 5 | 5.7% |
| 2018 | 8 | 9.2% |
| 2019 | 7 | 8.0% |
| 2020 | 11 | 12.6% |
| 2021 | 10 | 11.5% |
| 2022 | 7 | 8.0% |
| 2023 | 10 | 11.5% |
| 2024 | 19 | 21.8% |
| 2025 | 7 | 8.0% |
Top 15 of 19 technology areas
Overall rank by patents
#4,114
Across all tracked assignees
48.7 out of 100
How to use this portfolio
Daramic's 87 grants land it in the top 16% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.